326 reports of this reaction
15.3% of all OMEPRAZOLE, SODIUM BICARBONATE reports
#1 most reported adverse reaction
CHRONIC KIDNEY DISEASE is the #1 most commonly reported adverse reaction for OMEPRAZOLE, SODIUM BICARBONATE, manufactured by CVS Pharmacy. There are 326 FDA adverse event reports linking OMEPRAZOLE, SODIUM BICARBONATE to CHRONIC KIDNEY DISEASE. This represents approximately 15.3% of all 2,134 adverse event reports for this drug.
Patients taking OMEPRAZOLE, SODIUM BICARBONATE who experience chronic kidney disease should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CHRONIC KIDNEY DISEASE is a frequently reported adverse event for OMEPRAZOLE, SODIUM BICARBONATE, accounting for a significant proportion of all reports.
In addition to chronic kidney disease, the following adverse reactions have been reported for OMEPRAZOLE, SODIUM BICARBONATE:
The following drugs have also been linked to chronic kidney disease in FDA adverse event reports:
CHRONIC KIDNEY DISEASE has been reported as an adverse event in 326 FDA reports for OMEPRAZOLE, SODIUM BICARBONATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CHRONIC KIDNEY DISEASE accounts for approximately 15.3% of all adverse event reports for OMEPRAZOLE, SODIUM BICARBONATE, making it one of the most commonly reported side effect.
If you experience chronic kidney disease while taking OMEPRAZOLE, SODIUM BICARBONATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.